Cystinosis Pathophysiology and Therapeutic Approaches

Cystinosis is an autosomal recessive lysosomal storage disorder caused by biallelic mutations in the CTNS gene, which encodes the seven-transmembrane lysosomal exporter cystinosin. Loss of cystinosin function leads to intralysosomal accumulation of cystine, triggering cascades of cellular dysfunction across multiple organs, most notably the proximal tubular epithelium of the kidney. Pathogenic mechanisms include impaired autophagy, oxidative stress from accumulated damaged mitochondria, dysregulated nutrient‐sensing through constitutive activation of mechanistic target of rapamycin complex 1 (mTORC1) and defective endo-lysosomal trafficking. Current mainstay therapy employs the cystine-depleting agent cysteamine, which delays progression to end-stage renal disease and mitigates extrarenal complications but fails to reverse established proximal tubulopathy. Emerging strategies under investigation aim to correct protein misfolding via chemical chaperones, restore autophagic flux, modulate mTORC1 signalling, enable translational read-through of premature stop codons, and harness gene or stem cell-based interventions for durable correction.

Research from Nature Portfolio

Recent studies have revealed that defective cystine export through mutated cystinosin drives aberrant recruitment of the Ragulator–Rag GTPase complex and constitutive activation of mTORC1 in proximal tubular cells, diverting differentiation towards proliferation and undermining reabsorptive function. Restoration of cystinosin or application of cell-permeant cystine analogues reinstates nutrient-dependent mTORC1 regulation, while pharmacological mTORC1 inhibition rescues lysosomal integrity, epithelial differentiation and renal phenotypes in preclinical models. Foundational work has also elucidated the link between lysosomal overload and impaired autophagy: defective clearance of damaged mitochondria unleashes oxidative stress that triggers tight-junction signalling via ZO-1 and the Y-box factor ZONAB, culminating in transport defects. Targeting mitochondrial reactive oxygen species or blocking ZONAB signalling ameliorates epithelial dysfunction, underscoring the interplay between lysosomal health and tubular homeostasis.

Cystinosis Pathophysiology and Therapeutic Approaches publication trend

The graph below shows the total number of articles in cystinosis pathophysiology and therapeutic approaches across all publications each year (not limited to Nature Index journals).

Technical terms

Cystinosin: Lysosomal transmembrane transporter responsible for exporting cystine to the cytosol.

mTORC1: Mechanistic target of rapamycin complex 1, a nutrient-sensing kinase regulating cell growth and metabolism.

Autophagy: Lysosome-mediated degradation pathway for damaged organelles and proteins.

ER-associated degradation (ERAD): Quality control mechanism directing misfolded endoplasmic reticulum proteins to proteasomal degradation.

Chemical chaperone: Small molecule that assists protein folding and trafficking to their functional destinations.

Translational read-through: Pharmacological strategy that enables ribosomal bypass of premature stop codons during protein synthesis.

Reactive oxygen species (ROS): Highly reactive oxygen-containing molecules that can induce oxidative damage.

Proximal tubular cells: Kidney epithelial cells responsible for reabsorption of solutes and water from the filtrate.

References

1. Lysosomal cystine export regulates mTORC1 signaling to guide kidney epithelial cell fate specialization. Nature Communications (2023).
2. ER-associated degradation in cystinosis pathogenesis and the prospects of precision medicine. Journal of Clinical Investigation (2023).
3. Cystinosis: a review. Orphanet Journal of Rare Diseases (2016).
4. Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney. Nature Communications (2018).
5. Effects of long-term cysteamine treatment in patients with cystinosis. Pediatric Nephrology (2017).
6. The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis. PLOS ONE (2019).